Overview Our business Financial review Governance Financial statements and other information Reed Elsevier NV Notes to the consolidated financial statements for the year ended 31 December 2009 19 Principal joint ventures % holding Reed Elsevier Group plc Incorporated and operating in Great Britain 14,634 ordinary R shares 1-3 Strand 14,634 ordinary E shares 100% London WC2N 5JR 100,000 7.5% cumulative preference non-voting shares Holding company for operating businesses involved in science & medical, legal and business publishing and organisation of trade exhibitions Equivalent to a 50% equity interest Elsevier Reed Finance BV Incorporated in the Netherlands 133 ordinary R shares Radarweg 29 205 ordinary E shares 100% 1043 NX Amsterdam, the Netherlands Holding company for financing businesses Equivalent to a 61% equity interest The R shares in Reed Elsevier Group plc and Elsevier Reed Finance BV and the non-voting preference shares in Reed Elsevier Group plc are owned by Reed Elsevier PLC.
In addition, Reed Elsevier NV holds shares with special dividend rights in Reed Elsevier Overseas BV, a subsidiary of Reed Elsevier Group plc with registered offices in Amsterdam.
These shares are included in the amount shown under investments in joint ventures and enable Reed Elsevier NV to receive dividends from companies within the same tax jurisdiction.
A list of companies within Reed Elsevier is filed with the Amsterdam Chamber of Commerce in the Netherlands.
20 Approval of financial statements The consolidated financial statements were signed and authorised for issue by the Combined Board of directors on 17 February 2010.
A J Habgood M H Armour Chairman of the Supervisory Board Chief Financial Officer and the Combined Board Annual Reports and Financial Statements 2009 Reed Elsevier 177
